HALO logo
halo search icon
Castle Biosciences, Inc.
Castle Biosciences, Inc.
CSTL · NAS

Castle Biosciences, Inc.

US$20.54

Price Arrow0.51 (2.55%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO AllHALO Balance SheetHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Castle Biosciences, Inc. Overview

CSTL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

About CSTL

icon

Telephone

1.866.788.9007

icon

Address

Suite 400, 1500 West Parkwood Avenue, Friendswood, TX 77546

Description

Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.

CSTL Price Chart

Key Stats

Market Cap

US$607.51M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 14.59 - 44.28

Trade Value (12mth)

US$2,817,203.00

1 week

4.7%

1 month

-20.2%

YTD

-48.03%

1 year

26.05%

All time high

107.69

Key Fundamentals

EPS 3 yr Growth

-67.70%

EBITDA Margin

-0.60%

Operating Cashflow

$64m

Free Cash Flow Return

13.00%

ROIC

-4.90%

Interest Coverage

-23.70

Quick Ratio

5.10

Other Data

Shares Outstanding (Fully Diluted)

30m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CSTL Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
07 May 26
07 May 26

CSTL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.140.66-0.83locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.140.62-0.83locklocklock
Growth
%locklocklocklock16.8130.6-226.9locklocklock
PE
XlocklocklocklockN/A42.7N/Alocklocklock
EV/EBITDA
XlocklocklocklockN/A20.1N/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Castle Biosciences, Inc. (CSTL:NAS)?
Halo FAQ
The current share price of Castle Biosciences, Inc. (CSTL:NAS) is USD$20.54.
What is the 52-week high share price for Castle Biosciences, Inc. (CSTL:NAS)?
Halo FAQ
The 52-week high share price for Castle Biosciences, Inc. (CSTL:NAS) is USD$44.28.
What is the 52-week low share price for Castle Biosciences, Inc. (CSTL:NAS)?
Halo FAQ
The 52-week low share price for Castle Biosciences, Inc. (CSTL:NAS) is USD$14.59.
What is the dividend yield for Castle Biosciences, Inc. (CSTL:NAS)?
Halo FAQ
Castle Biosciences, Inc. (CSTL:NAS) does not pay a dividend.
What was Castle Biosciences, Inc. (CSTL:NAS) last dividend payment?
Halo FAQ
Castle Biosciences, Inc. (CSTL:NAS) does not pay a dividend.
What is the franking level for Castle Biosciences, Inc. (CSTL:NAS)?
Halo FAQ
Castle Biosciences, Inc. (CSTL:NAS) has a franking level of 0.00%.
In which sector is Castle Biosciences, Inc. (CSTL:NAS) classified?
Halo FAQ
Castle Biosciences, Inc. (CSTL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.